![malaysia news lab](https://www.ammtv.my/wp-content/uploads/2020/08/ruvaccine-800x400.jpg)
(CNN)Russia announced on Thursday that it will begin post-registration clinical trials for its Covid-19 vaccine candidate next week — and 40,000 people will participate.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said during a telebriefing with journalists that the trials will take place in several countries.